1363rd Industry Alliance

The latest website: In fact, there are many raw material drug companies in China. It is not even an exaggeration to say that we are the world's largest producer of raw material drugs.

But why can we produce the most raw materials, but not when producing high-end finished products?

For example, penicillin, the most commonly used broad-spectrum antibiotic on the market, has been discovered for hundreds of years.

It still plays a very wide role in the medical field. This antibiotic can not only be used as an anti-inflammatory and bactericidal drug itself, but also can be used as the basic raw material of many other drugs.

But it is such a common drug with a very wide range of uses, but our country still has to import a large amount from abroad.

The main import target is Roche in Switzerland.

Why? Just because we can't do well!

Don't look at the same penicillin, such as the oral one.

It takes longer for our products to be absorbed by the human body and enter the blood circulation than others.

Other people's drugs can reach the peak concentration in the blood more quickly, and the time they exist in the blood, that is, the duration of the drug effect in popular understanding, is longer than ours.

In this way, the effect of other people's medicine will naturally be better.

According to comparative analysis, the efficacy of the penicillin we produce is basically about 80% of that of Roche.

Moreover, the price of other people's penicillin, even if it is shipped to Hong Kong by sea, is not much more expensive than ours.

So who do you think the pharmaceutical factory will purchase?

The reason why Roche's penicillin can do so well.

The main reason is that it has its own unique secrets in the process.

For many drugs, even though the patent protection period has expired, many pharmaceutical manufacturers can imitate them.

But although you know the molecular formula and synthesis method of others, you may not be able to make medicines with the same effect as others.

Because the reverse research and development of drugs is not as simple as everyone imagines, but the difficulty is very high.

Because many pharmaceutical factories have their own unique technology and procedures, and it is these that determine the effect of the drug.

Even in order to make the medicine exert the best effect, many of their production equipment are specially designed.

And this point, if you don't go deep into it, or if you don't go to other people's factories to see it with your own eyes, it is impossible for you to know it.

This is also the main reason why generic drugs in India are so awesome.

At present, in the whole world, the companies that can make the medicines look like the real ones, and even restore almost 100% of the original medicines, that is, several pharmaceutical companies in India can do it.

Even if the technology is as strong as that of Japan, it cannot achieve the imitation ability of Indian pharmaceutical companies.

What Xiao Feng has to do now is to learn from India and improve the research and development capabilities of domestic pharmaceutical companies in generic drugs.

To be honest, anyone who knows domestic pharmaceutical companies knows that the positive research and development capabilities of our domestic pharmaceutical companies are really too weak now.

Because in the past few decades, we just focused on developing the economy, and everyone was desperately expanding the scale.

Enterprises do not have much money to invest in research and development, especially pharmaceutical companies, once they want to engage in research and development, the investment is really too large.

Moreover, the research and development cycle is still long. Even if it is finally developed, it will take a long period of clinical trials before it can be approved.

However, the cost of conducting clinical trials in China is very high, and there are still many restrictions in various aspects.

Therefore, all domestic pharmaceutical companies do not like to engage in research and development.

This has caused us to owe too much debt. In recent years, the higher authorities have also noticed this problem, so many policies have been introduced to encourage and stimulate pharmaceutical companies to engage in positive research and development.

In recent years, many domestic pharmaceutical companies have increased their investment in this area.

But for the results, it may have to wait a few years.

After all, the research and development of medicines will take several years from the time of development, and then it will take several years to conduct clinical trials.

Therefore, the results will not be produced in one or two years.

Many of the upstream and downstream enterprises surrounding the Ninth Laboratory are actually small and medium-sized enterprises with low anti-risk capabilities.

The industries in which these small and medium-sized enterprises are engaged in have low technical requirements and entry barriers, so the competition is also very fierce.

The anti-risk ability of these small and medium-sized enterprises can be said to be very poor. Maybe this year they won the order of the Ninth Laboratory and lived very well.

But next year, if the order is taken away by another company, it will not be able to survive, and it may go bankrupt.

Originally, how these companies are doing is not related to the Ninth Laboratory.

But now Xiao Feng and He Xiaojun said that he wants to select a few companies with self-motivation in the upstream and downstream industrial chain of the Ninth Laboratory to support them.

And his purpose of establishing this Quanye Fund is actually to create an industrial alliance with the Ninth Laboratory as the core.

After all, no one knows what kind of risks the company will encounter in the future. As the saying goes, one hero has three gangs.

In the future, if the Ninth Laboratory encounters any danger, it will bring a younger brother who can be a human shield and charge forward at any time.

That's better than fighting alone by yourself.

And sometimes, when you encounter some things, it is inconvenient for you to come forward by yourself, but the younger brother around you can jump out and help you solve them.

This is also one of the main reasons why Xiao Feng wants to build this alliance.

"Well, I will ask the people below to sort out a detailed list of our upstream and downstream enterprises."

"At that time, I will let our people select some companies from it."

He Xiaojun also fully understood Xiao Feng's intention at this time, so he also strongly agreed with this idea.

"Well, remember to ask our people to have a good chat with the owners of those companies, and remember that we invest in people, not their companies!"

Xiao Feng knocked on the table and said the important point, He Xiaojun also nodded, he understood Xiao Feng's meaning very well.

The enterprises they want to support are definitely not the kind of enterprises with a smooth surface.

The enterprises they want to support are those whose owners have ambitions.

It is the kind of owner who is absolutely not reconciled, and only makes drug packaging for the Ninth Laboratory, or supplies raw materials.

It's the kind of owner who has made money and wants to enter an industry with a technical moat, a self-motivated entrepreneur.

After all, in this impetuous era, there is a need for this kind of business owner who is dedicated to doing business, who can endure loneliness, resist temptation, and is willing to work intensively on his own one-third of an acre of land.

Having been in business for so many years, Xiao Feng believes that only such owners can become big players in the future.

To be honest, although many business people in China are saying that business is difficult, there are still many bosses who insist on doing business.

However, many of these bosses are eliminated by the industry every year.

There are also many bosses who feel very confused, why is it so difficult to do business now.

Because our current situation is that we have entered the stage of the middle-class country trap.

In the past, what we did was the simplest primary processing industry. These industries mainly relied on labor force, that is, highly polluting labor-intensive industries.

This kind of industry has low barriers to entry, so once you see making money, it is easy to fight and swarm.

The final outcome is that various business owners bargained with each other, keeping the profits very low, and finally let the foreign purchasers pick up the bargain.

But now many entrepreneurs have understood this point, and they don't seem to be working at the bottom of the industry chain, and they all want to hit the peak.

However, the upstream of the industrial chain has always been a high-profit area controlled by developed countries in Europe, America, Japan, and South Korea. How can it be so easy to make breakthroughs in this area?

Therefore, many entrepreneurs today will lament that the current industry is too difficult to do.

As for the small and medium-sized enterprises around the Ninth Laboratory, if they are asked to make original research medicines as soon as they come up, it is tantamount to asking them to commit suicide.

This is very unrealistic, so Xiao Feng's idea is to let them start with generic drugs.

After all, the patents of generic drugs are basically public now, and the difference between everyone is the technology and process.

And in this regard, for the cloning experts in the Ninth Laboratory, it is not difficult at all.

As for making generic drugs, for the current Ninth Laboratory, they don't bother to do it. After all, they are now the world's first-tier pharmaceutical companies.

Going to make generic drugs is a bit of a self-depreciation.

But the market for generic drugs is not small at all. Xiao Feng does not want to see foreign pharmaceutical companies relying on generic drugs to gain ground in our domestic market.

And now Mr. Wan's Penglai Pavilion app is getting more and more popular, and now it seems to have become the most popular app for seeking medical advice in China.

And Wan Gongzi's Neptune chain pharmacy has also quietly flourished in the past more than a year.

Regarding this Haiwang pharmacy, their development can be said to be extremely low-key, although it has expanded rapidly across the country for more than a year.

But there has never been any advertising, but almost all the pharmacies recommended by doctors on the Penglaige APP are this one.

So this pharmacy has now become a favorite in the eyes of all pharmaceutical companies.

Just like ordinary large shopping supermarkets, almost all pharmaceutical factories now want to put their own medicines on their shelves.

Therefore, this Neptune drugstore chain has a faint tendency to become the number one chain drugstore in China.

Therefore, if these upstream and downstream enterprises supported by the Ninth Laboratory really make generic drugs, then the sales channel will definitely not be a problem.

Xiao Feng has already helped those bosses think about everything.

As long as those bosses have ambitions, then their Ninth Laboratory can definitely provide sufficient financial support and technical support.

Of course, these are all to be converted into shares, if the company makes profits in the future.

Then the Ninth Laboratory will enjoy the dividends.